VRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $16,807,423.22

Vertex Pharmaceuticals Insider Trading History Chart

Vertex Pharmaceuticals Share Price & Price History

^$464.20

▼ -8.15 (-1.73%)

As of 07/15/2025 05:00 PM ET

Days: 30 | 90 | 365

Vertex Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/15/2025	David Altshuler	EVP	Sell	52	$424.69	$22,083.88	23,281
3/10/2025	David Altshuler	EVP	Sell	3,231	$500.00	$1,615,500.00	26,512
2/27/2025	Ourania Tatsis	EVP	Sell	530	$475.34	$251,930.20	58,539
2/18/2025	Ourania Tatsis	EVP	Sell	244	$455.06	$111,034.64	67,695
2/11/2025	Ourania Tatsis	EVP	Sell	310	$459.83	$142,547.30	64,021
11/15/2024	David Altshuler	EVP	Sell	15	$478.56	$7,178.40	25,813
8/30/2024	Jeffrey M. Leiden	Chairman	Sell	3,784	$499.00	$1,888,216.00	9,994
8/30/2024	Sangeeta N Bhatia	Director	Sell	646	$500.00	$323,000.00	4,435
8/7/2024	Carmen Bozic	CMO	Sell	2,280	$476.75	$1,086,990.00	23,259
8/1/2024	Bruce I. Sachs	Director	Sell	5,295	$508.00	$2,689,860.00	40,000
7/24/2024	Carmen Bozic	CMO	Sell	2,280	$488.46	$1,113,688.80	25,539
7/22/2024	Reshma Kewalramani	CEO	Sell	15,202	$497.00	$7,555,394.00	106,172
7/10/2024	Carmen Bozic	CMO	Sell	2,280	$487.34	$1,111,135.20	27,819
6/26/2024	Carmen Bozic	CMO	Sell	2,280	$471.72	$1,075,521.60	30,099
6/12/2024	Carmen Bozic	CMO	Sell	2,280	$478.00	$1,089,840.00	32,379
6/12/2024	E. Morrey Atkinson, III	EVP	Sell	7,288	$478.00	$3,483,664.00	15,972
5/30/2024	Ourania Tatsis	EVP	Sell	2,350	$439.11	$1,031,908.50	53,523
5/29/2024	Carmen Bozic	CMO	Sell	2,280	$445.56	$1,015,876.80	34,659
5/28/2024	Charles F. Wagner, Jr.	CFO	Sell	3,250	$454.79	$1,478,067.50	50,387
5/24/2024	Reshma Kewalramani	CEO	Sell	1,565	$457.00	$715,205.00	121,374
5/22/2024	Bruce I. Sachs	Director	Sell	7,073	$448.00	$3,168,704.00	40,000
2/26/2024	Ourania Tatsis	EVP	Sell	354	$425.70	$150,697.80	55,804
2/20/2024	Ourania Tatsis	EVP	Sell	480	$420.79	$201,979.20	59,827
2/12/2024	Amit Sachdev	EVP	Sell	3,222	$420.24	$1,354,013.28	74,364
2/12/2024	Jeffrey M. Leiden	Chairman	Sell	2,656	$419.51	$1,114,218.56	27,644
2/12/2024	Kristen Ambrose	CAO	Sell	1,374	$420.24	$577,409.76	9,676
2/12/2024	Stuart A. Arbuckle	COO	Sell	4,295	$420.24	$1,804,930.80	75,718
1/8/2024	Jeffrey M. Leiden	Chairman	Sell	6,648	$419.07	$2,785,977.36	2,423
11/6/2023	Bruce I. Sachs	Director	Sell	11,250	$385.00	$4,331,250.00	40,000
10/31/2023	Carmen Bozic	CMO	Sell	5,651	$355.92	$2,011,303.92	34,952
10/17/2023	Carmen Bozic	CMO	Sell	5,651	$373.25	$2,109,235.75	40,603
10/17/2023	Sangeeta N Bhatia	Director	Sell	243	$375.00	$91,125.00	3,901
10/16/2023	Jeffrey M. Leiden	Chairman	Sell	12,962	$374.00	$4,847,788.00	22,425
10/6/2023	Sangeeta N Bhatia	Director	Sell	242	$360.00	$87,120.00	4,144
10/3/2023	Carmen Bozic	CMO	Sell	5,651	$345.28	$1,951,177.28	46,254
10/2/2023	Jonathan Biller	EVP	Sell	610	$346.76	$211,523.60	10,569
9/19/2023	Carmen Bozic	CMO	Sell	5,651	$351.00	$1,983,501.00	51,905
8/23/2023	Ourania Tatsis	EVP	Sell	2,500	$355.00	$887,500.00	48,637
8/9/2023	David Altshuler	EVP	Sell	63	$345.51	$21,767.13	32,038
8/9/2023	Sangeeta N Bhatia	Director	Sell	242	$345.51	$83,613.42	4,386
7/17/2023	Bruce I. Sachs	Director	Sell	11,250	$356.75	$4,013,437.50	40,000
7/17/2023	Reshma Kewalramani	CEO	Sell	7,828	$355.00	$2,778,940.00	118,906
6/15/2023	Stuart A. Arbuckle	COO	Sell	8,603	$349.00	$3,002,447.00	56,556
5/30/2023	Kristen Ambrose	CAO	Sell	289	$329.82	$95,317.98	6,838
5/30/2023	Stuart A. Arbuckle	COO	Sell	82	$329.82	$27,045.24	56,556
5/8/2023	Bastiano Sanna	EVP	Sell	2,850	$350.00	$997,500.00	32,038
5/8/2023	Jeffrey M. Leiden	Chairman	Sell	1,125	$349.00	$392,625.00	35,387
5/5/2023	Bastiano Sanna	EVP	Sell	422	$350.03	$147,712.66	34,888
5/5/2023	Jeffrey M. Leiden	Chairman	Sell	879	$349.56	$307,263.24	36,512
5/2/2023	Bastiano Sanna	EVP	Sell	1,622	$350.66	$568,770.52	38,091
5/2/2023	Jeffrey M. Leiden	Chairman	Sell	6,450	$349.89	$2,256,790.50	41,899
5/2/2023	Sangeeta N Bhatia	Director	Sell	580	$348.28	$202,002.40	4,628
4/27/2023	Reshma Kewalramani	CEO	Sell	3,317	$339.08	$1,124,728.36	126,652
4/12/2023	Bastiano Sanna	EVP	Sell	7,567	$326.70	$2,472,138.90	39,713
4/12/2023	Bruce I. Sachs	Director	Sell	21,300	$326.73	$6,959,349.00	41,210
4/4/2023	Bastiano Sanna	EVP	Sell	522	$315.81	$164,852.82	47,280
3/24/2023	Charles F. Wagner, Jr.	CFO	Sell	1,768	$305.38	$539,911.84	49,611
3/17/2023	Charles F. Wagner, Jr.	CFO	Sell	2,000	$296.39	$592,780.00	51,379
3/16/2023	Bastiano Sanna	EVP	Sell	2,746	$300.59	$825,420.14	49,268
3/13/2023	Charles F. Wagner, Jr.	CFO	Sell	2,666	$293.83	$783,350.78	53,379
3/10/2023	Charles F. Wagner, Jr.	CFO	Sell	2,088	$289.61	$604,705.68	56,045
2/27/2023	Kristen Ambrose	CAO	Sell	1,207	$287.55	$347,072.85	7,303
2/27/2023	Ourania Tatsis	EVP	Sell	354	$287.48	$101,767.92	56,805
2/27/2023	Stuart A. Arbuckle	COO	Sell	5,034	$287.47	$1,447,123.98	56,556
2/22/2023	Stuart A. Arbuckle	COO	Sell	2,401	$294.33	$706,686.33	66,304
2/13/2023	Ourania Tatsis	EVP	Sell	275	$298.99	$82,222.25	65,765
2/13/2023	Stuart A. Arbuckle	COO	Sell	4,887	$298.92	$1,460,822.04	82,003
2/6/2023	David Altshuler	EVP	Sell	1,304	$306.00	$399,024.00	68,645
1/30/2023	Lloyd Carney	Director	Sell	2,700	$320.52	$865,404.00	4,150
1/27/2023	Yuchun Lee	Director	Sell	1,429	$322.03	$460,180.87	1,875
1/25/2023	Reshma Kewalramani	CEO	Sell	10,000	$315.05	$3,150,500.00	89,598
1/25/2023	Yuchun Lee	Director	Sell	4,000	$313.96	$1,255,840.00	1,875
1/23/2023	Yuchun Lee	Director	Sell	2,129	$312.02	$664,290.58	1,875
1/18/2023	Yuchun Lee	Director	Sell	442	$312.17	$137,979.14	1,875
11/7/2022	David Altshuler	EVP	Sell	1,303	$303.04	$394,861.12	36,077
10/24/2022	Sangeeta N Bhatia	Director	Sell	621	$310.00	$192,510.00	4,040
10/18/2022	Bastiano Sanna	EVP	Sell	1,791	$300.31	$537,855.21	39,192
8/15/2022	Joy Liu	SVP	Sell	3,747	$303.90	$1,138,713.30	9,605
8/15/2022	Reshma Kewalramani	CEO	Sell	11,689	$305.06	$3,565,846.34	99,598
8/15/2022	Stuart A. Arbuckle	COO	Sell	22,173	$303.93	$6,739,039.89	45,278
8/9/2022	Joy Liu	SVP	Sell	946	$300.00	$283,800.00	13,388
8/9/2022	Ourania Tatsis	EVP	Sell	1,400	$298.97	$418,558.00	46,090
8/9/2022	Stuart A. Arbuckle	COO	Sell	5,690	$300.67	$1,710,812.30	60,996
8/8/2022	Sangeeta N Bhatia	Director	Sell	621	$293.03	$181,971.63	4,661
7/29/2022	Sangeeta N Bhatia	Director	Sell	621	$278.77	$173,116.17	5,282
7/25/2022	Jeffrey M. Leiden	Chairman	Sell	132,079	$281.38	$37,164,389.02	2,423
7/19/2022	David Altshuler	EVP	Sell	17,865	$288.65	$5,156,732.25	36,077

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

90.96% of Vertex Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vertex Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/15/2025	Financial Management Professionals Inc.	60	$27K	0.0%	-31.8%	0.000%
7/15/2025	Ballentine Partners LLC	5,428	$2.42M	0.0%	-7.0%	0.002%
7/15/2025	Cigna Investments Inc. New	2,539	$1.13M	0.2%	-2.4%	0.001%
7/15/2025	Norden Group LLC	2,575	$1.15M	0.1%	+44.0%	0.001%
7/15/2025	Accurate Wealth Management LLC	1,044	$0.50M	0.1%	-26.9%	0.000%
7/15/2025	Fifth Third Bancorp	24,224	$10.79M	0.0%	-6.1%	0.009%
7/15/2025	CCM Investment Advisers LLC	29,615	$13.19M	1.4%	+7.5%	0.012%
7/15/2025	Hall Laurie J Trustee	5,565	$2.48M	0.8%	+0.7%	0.002%
7/15/2025	Forte Capital LLC ADV	12,587	$5.60M	0.6%	+1.1%	0.005%
7/14/2025	AdvisorNet Financial Inc	1,674	$0.75M	0.0%	+13.6%	0.001%
7/14/2025	Foster Group Inc.	462	$0.21M	0.0%	-12.0%	0.000%
7/14/2025	GAMMA Investing LLC	4,712	$2.10M	0.1%	-5.8%	0.002%
7/14/2025	Lewis Asset Management LLC	495	$0.22M	0.1%	-33.6%	0.000%
7/14/2025	Park Avenue Securities LLC	15,362	$6.84M	0.1%	+0.1%	0.006%
7/14/2025	Avanza Fonder AB	25,425	$11.32M	0.3%	+5.8%	0.010%
7/14/2025	Atle Fund Management AB	24,328	$10.83M	4.6%	+6.7%	0.009%
7/14/2025	Sowell Financial Services LLC	2,797	$1.25M	0.1%	-1.0%	0.001%
7/11/2025	BTC Capital Management Inc.	11,928	$5.31M	0.4%	+5.2%	0.005%
7/11/2025	Orrstown Financial Services Inc.	1,137	$0.51M	0.1%	+16.4%	0.000%
7/11/2025	Farther Finance Advisors LLC	2,906	$1.29M	0.0%	+1.2%	0.001%
7/11/2025	Silver Oak Securities Incorporated	381	$0.17M	0.0%	N/A	0.000%
7/11/2025	CX Institutional	1,754	$0.78M	0.0%	-1.8%	0.001%
7/11/2025	Harbour Capital Advisors LLC	6,367	$2.91M	0.6%	+2.3%	0.002%
7/11/2025	UMB Bank n.a.	2,303	$1.03M	0.0%	-32.2%	0.001%
7/11/2025	My Legacy Advisors LLC	2,263	$1.09M	0.4%	+2.9%	0.001%
7/11/2025	AA Financial Advisors LLC	632	$0.28M	0.1%	N/A	0.000%
7/11/2025	SeaCrest Wealth Management LLC	474	$0.21M	0.0%	-37.9%	0.000%
7/11/2025	Assenagon Asset Management S.A.	242,754	$108.07M	0.2%	+16.6%	0.095%
7/11/2025	Perpetual Ltd	679	$0.30M	0.0%	+9.0%	0.000%
7/11/2025	Livforsakringsbolaget Skandia Omsesidigt	1,880	$0.84M	0.0%	-93.2%	0.001%
7/11/2025	Kingstone Capital Partners Texas LLC	48,792	$23.87M	0.0%	N/A	0.019%
7/11/2025	IFM Investors Pty Ltd	50,317	$22.40M	0.2%	+3.7%	0.020%
7/10/2025	Anderson Hoagland & Co.	19,647	$8.75M	0.8%	-0.9%	0.008%
7/10/2025	Moody National Bank Trust Division	3,441	$1.53M	0.1%	-2.6%	0.001%
7/10/2025	YHB Investment Advisors Inc.	891	$0.40M	0.0%	-5.3%	0.000%
7/10/2025	Redhawk Wealth Advisors Inc.	5,268	$2.35M	0.3%	+12.5%	0.002%
7/10/2025	Baker Tilly Wealth Management LLC	2,908	$1.30M	0.5%	-2.7%	0.001%
7/10/2025	Exchange Traded Concepts LLC	2,586	$1.15M	0.0%	-1.4%	0.001%
7/10/2025	Marshall Financial Group LLC	512	$0.24M	0.0%	-21.0%	0.000%
7/10/2025	Andrew Hill Investment Advisors Inc.	8,003	$3.56M	2.9%	+21.8%	0.003%
7/10/2025	Fulton Bank N.A.	847	$0.38M	0.0%	+47.8%	0.000%
7/10/2025	Wealth Enhancement Advisory Services LLC	82,641	$37.98M	0.1%	+3.1%	0.032%
7/10/2025	SK Wealth Management LLC	927	$0.44M	0.2%	-36.4%	0.000%
7/10/2025	Wedmont Private Capital	5,284	$2.53M	0.1%	+21.3%	0.002%
7/10/2025	Swedbank AB	254,347	$113.24M	0.1%	-12.3%	0.099%
7/10/2025	Baader Bank Aktiengesellschaft	2,357	$1.05M	0.1%	+112.3%	0.001%
7/10/2025	Sumitomo Mitsui DS Asset Management Company Ltd	48,090	$21.41M	0.2%	+3.7%	0.019%
7/10/2025	Focus Financial Network Inc.	606	$0.27M	0.0%	+5.8%	0.000%
7/10/2025	Sovran Advisors LLC	1,385	$0.65M	0.1%	-74.8%	0.001%
7/9/2025	Sivia Capital Partners LLC	657	$0.29M	0.1%	-9.5%	0.000%
7/9/2025	Channel Wealth LLC	13,877	$6.18M	1.7%	+578.9%	0.005%
7/9/2025	PFW Advisors LLC	545	$0.24M	0.1%	-32.0%	0.000%
7/9/2025	Chesley Taft & Associates LLC	596	$0.27M	0.0%	+22.6%	0.000%
7/9/2025	Sapient Capital LLC	36,310	$16.17M	0.3%	+0.9%	0.014%
7/9/2025	Procyon Advisors LLC	4,428	$1.97M	0.2%	-76.2%	0.002%
7/9/2025	Pallas Capital Advisors LLC	3,059	$1.36M	0.1%	+23.3%	0.001%
7/9/2025	Gateway Investment Advisers LLC	65,794	$29.29M	0.3%	-0.1%	0.026%
7/9/2025	Aaron Wealth Advisors LLC	3,219	$1.43M	0.1%	-2.7%	0.001%
7/9/2025	Breakwater Capital Group	1,839	$0.82M	0.1%	+3.0%	0.001%
7/9/2025	Balefire LLC	520	$0.23M	0.1%	N/A	0.000%
7/9/2025	New England Research & Management Inc.	1,060	$0.47M	0.2%	N/A	0.000%
7/9/2025	Fragasso Financial Advisors Inc	1,254	$0.56M	0.0%	+12.9%	0.000%
7/9/2025	Woodstock Corp	4,005	$1.78M	0.2%	-4.1%	0.002%
7/9/2025	Veracity Capital LLC	1,994	$0.89M	0.3%	-5.1%	0.001%
7/9/2025	Czech National Bank	62,770	$27.95M	0.2%	+6.4%	0.024%
7/9/2025	Livforsakringsbolaget Skandia Omsesidigt	1,880	$0.84M	0.0%	-93.2%	0.001%
7/9/2025	MassMutual Private Wealth & Trust FSB	26,791	$11.93M	0.3%	+57.4%	0.010%
7/8/2025	Little House Capital LLC	5,830	$2.60M	0.7%	-7.6%	0.002%
7/8/2025	Everpar Advisors LLC	792	$0.35M	0.2%	+5.9%	0.000%
7/8/2025	Baker Ellis Asset Management LLC	1,052	$0.47M	0.1%	-17.4%	0.000%
7/8/2025	Atwood & Palmer Inc.	55,192	$24.57M	1.5%	+0.4%	0.021%
7/8/2025	Granite Bay Wealth Management LLC	900	$0.40M	0.1%	+50.0%	0.000%
7/8/2025	Paladin Wealth LLC	1,240	$0.55M	0.4%	N/A	0.000%
7/8/2025	RMR Wealth Builders	5,100	$2.27M	0.2%	+5.5%	0.002%
7/8/2025	Heartwood Wealth Advisors LLC	568	$0.25M	0.0%	+5.6%	0.000%
7/8/2025	Gradient Investments LLC	38,013	$16.92M	0.3%	N/A	0.015%
7/8/2025	E. Ohman J or Asset Management AB	10,520	$4.68M	0.1%	-8.4%	0.004%
7/8/2025	GK Wealth Management LLC	689	$0.31M	0.3%	N/A	0.000%
7/8/2025	Parallel Advisors LLC	5,266	$2.34M	0.0%	-3.4%	0.002%
7/7/2025	Teamwork Financial Advisors LLC	519	$0.23M	0.0%	-28.2%	0.000%
7/7/2025	HMS Capital Management LLC	948	$0.42M	0.2%	-11.4%	0.000%
7/7/2025	Bangor Savings Bank	4,929	$2.19M	0.2%	-7.6%	0.002%
7/7/2025	Thurston Springer Miller Herd & Titak Inc.	2,727	$1.21M	0.2%	+25.4%	0.001%
7/7/2025	Salem Investment Counselors Inc.	494	$0.22M	0.0%	+54.4%	0.000%
7/7/2025	Centurion Wealth Management LLC	501	$0.22M	0.1%	N/A	0.000%
7/7/2025	RDA Financial Network	4,851	$2.16M	0.6%	-4.1%	0.002%
7/3/2025	TrueWealth Advisors LLC	1,223	$0.54M	0.2%	+12.4%	0.000%
7/3/2025	Sage Capital Advisors llc	715	$0.32M	0.1%	+19.0%	0.000%
7/2/2025	Capital Market Strategies LLC	670	$0.30M	0.2%	-34.3%	0.000%
7/2/2025	LVM Capital Management Ltd. MI	30,070	$13.39M	1.4%	+0.5%	0.012%
7/2/2025	Central Pacific Bank Trust Division	5,559	$2.48M	0.3%	+2.5%	0.002%
6/26/2025	AG2R LA Mondiale Gestion D Actifs	9,601	$4.24M	0.2%	N/A	0.004%
6/23/2025	Swedbank AB	290,074	$140.63M	0.2%	-36.5%	0.113%
6/18/2025	Voya Investment Management LLC	827,138	$400.72M	0.4%	+18.4%	0.322%
6/17/2025	Howe & Rusling Inc.	9,126	$4.42M	0.4%	+2.6%	0.004%
6/9/2025	1248 Management LLC	1,795	$0.87M	0.4%	-13.1%	0.001%
6/5/2025	Cim LLC	475	$0.23M	0.0%	-85.1%	0.000%
6/4/2025	First Hawaiian Bank	5,404	$2.62M	0.1%	+9.3%	0.002%
6/2/2025	Modern Wealth Management LLC	946	$0.46M	0.0%	N/A	0.000%
5/28/2025	Anderson Financial Strategies LLC	355	$0.17M	0.1%	N/A	0.000%

Data available starting January 2016

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor. The company's pipeline includes VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX-548, a non-opioid medicine for the treatment of acute and neuropathic pain which is in Phase 3 clinical trial; Exa-cel, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial. In addition, it provides inaxaplin for the treatment of APOL1-mediated focal segmental glomerulosclerosis and co-morbidities, such as hypertension which is in single Phase 2/3; VX- 880 and VX-264, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-970, which is in Phase 2 clinical trial for the treatment of cancer; and VX-803 and VX-984 for treatment of cancer in Phase 1 clinical trial. Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; Entrada Therapeutics, Inc.; Arbor Biotechnologies, Inc.; Mammoth Biosciences, Inc.; and Verve Therapeutics., as well as collaborations with Tevard Biosciences to develop novel tRNA-based therapies for duchenne muscular dystrophy. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $464.20

$463.40

$475.29

50 Day Range

MA: $447.15

$421.16

$479.53

52 Week Range

Now: $464.20

$377.85

$519.88

Volume

988,008 shs

Average Volume

1,424,508 shs

Market Capitalization

$119.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.41

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top insider shareholders include:
Reshma Kewalramani (CEO)
Stuart A Arbuckle (COO)
Amit Sachdev (EVP)
Ourania Tatsis (EVP)
Carmen Bozic (CMO)
Charles F Wagner Jr (CFO)
Bruce I Sachs (Director)
David Altshuler (EVP)
Jeffrey M Leiden (Chairman)
Edward Morrow Atkinson III (EVP)
Jonathan Biller (EVP)
Kristen Ambrose (CAO)
Sangeeta N Bhatia (Director)
Learn More about top insider investors at Vertex Pharmaceuticals.
Who are the major institutional investors of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top institutional investors include:
Swedbank AB — 0.10%
Assenagon Asset Management S.A. — 0.09%
Public Employees Retirement System of Ohio — 0.04%
Wealth Enhancement Advisory Services LLC — 0.03%
Beacon Investment Advisory Services Inc. — 0.03%
Gateway Investment Advisers LLC — 0.03%
Learn More about top institutional investors of Vertex Pharmaceuticals stock.
Which major investors are selling Vertex Pharmaceuticals stock?: Within the previous quarter, VRTX stock was sold by these institutional investors:
Swedbank AB
Livforsakringsbolaget Skandia Omsesidigt
Livforsakringsbolaget Skandia Omsesidigt
Procyon Advisors LLC
Sovran Advisors LLC
Public Employees Retirement System of Ohio
TD Private Client Wealth LLC
Fifth Third Bancorp
In the last year, company insiders that have sold Vertex Pharmaceuticals company stock include:
Reshma Kewalramani (CEO)
Stuart A Arbuckle (COO)
Amit Sachdev (EVP)
Ourania Tatsis (EVP)
Carmen Bozic (CMO)
Charles F Wagner Jr (CFO)
Bruce I Sachs (Director)
Learn More investors selling Vertex Pharmaceuticals stock.
Which major investors are buying Vertex Pharmaceuticals stock?: During the previous quarter, VRTX stock was acquired by institutional investors including:
Kingstone Capital Partners Texas LLC
Gradient Investments LLC
Assenagon Asset Management S.A.
Channel Wealth LLC
MassMutual Private Wealth & Trust FSB
Harrell Investment Partners LLC
Czech National Bank
Wealth Enhancement Advisory Services LLC